Innovative therapies for vitiligo
Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo
Author: OI Team
Posts by OI Team
Understanding hidradenitis suppurativa
Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa
